|Articles|November 2, 2017
New Site Metrix Helps Pharma Inform Clinical Trial Plans
Advertisement
KMR Group announces its newest release of Site Metrix Application which provides clinical site performance benchmarks to the biopharma industry. The application will be used to help biopharma in the performance evaluation of their sites and set realistic site level enrollment plans. Accessing this data will no longer pose a challenge as well.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
2
Generative AI Transforms Clinical Study Report Development
3
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
4
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
5